HyBrow: a prototype system for computer-aided hypothesis evaluation.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 15262807)

Published in Bioinformatics on August 04, 2004

Authors

S A Racunas1, N H Shah, I Albert, N V Fedoroff

Author Affiliations

1: The Huck Institute for Life Sciences, Penn State University, University Park, PA 16801, USA.

Articles by these authors

Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science (1996) 9.12

Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science (1997) 8.99

Association of the APC gene product with beta-catenin. Science (1993) 8.20

Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A (1995) 7.31

The nucleotide sequence of oocyte 5S DNA in Xenopus laevis. II. The GC-rich region. Cell (1978) 5.87

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell (1988) 5.42

Fundamental patterns underlying gene expression profiles: simplicity from complexity. Proc Natl Acad Sci U S A (2000) 5.19

The nucleotide sequence of the maize controlling element Activator. Cell (1984) 4.64

The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol (1999) 4.06

CLENCH: a program for calculating Cluster ENriCHment using the Gene Ontology. Bioinformatics (2004) 3.93

The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res (1994) 3.57

Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther (2013) 3.44

Genetic and molecular analysis of the Spm-dependent a-m2 alleles of the maize a locus. Genetics (1987) 3.34

Dynamic modeling of gene expression data. Proc Natl Acad Sci U S A (2001) 3.24

Pharmacovigilance using clinical notes. Clin Pharmacol Ther (2013) 2.63

The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin. J Biol Chem (1995) 2.62

Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther (2012) 2.56

The nucleotide sequence of oocyte 5S DNA in Xenopus laevis. I. The AT-rich spacer. Cell (1978) 2.50

RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J (1993) 2.38

A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell (1990) 2.10

On spacers. Cell (1979) 1.99

Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol (1996) 1.94

Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res (1997) 1.91

Deletions within a defective suppressor-mutator element in maize affect the frequency and developmental timing of its excision from the bronze locus. Proc Natl Acad Sci U S A (1985) 1.86

Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Oncogene (1997) 1.83

A transposon insertion in the Arabidopsis SSR16 gene causes an embryo-defective lethal mutation. Plant J (1996) 1.76

Development of a novel controlled-release system for gastric retention. Pharm Res (1997) 1.74

Genetic ablation of root cap cells in Arabidopsis. Proc Natl Acad Sci U S A (1999) 1.66

Mobility of the maize suppressor-mutator element in transgenic tobacco cells. Proc Natl Acad Sci U S A (1989) 1.59

Characterization and mapping of Ds-GUS-T-DNA lines for targeted insertional mutagenesis. Plant J (1996) 1.55

Mitogen-activated protein kinase signaling in postgermination arrest of development by abscisic acid. Proc Natl Acad Sci U S A (2002) 1.54

BioPortal: ontologies and data resources with the click of a mouse. AMIA Annu Symp Proc (2008) 1.54

LRP1, a gene expressed in lateral and adventitious root primordia of arabidopsis. Plant Cell (1995) 1.53

Safety and efficacy of an oil-adjuvant vaccine against haemorrhagic septicaemia in buffalo calves: cross-protection between the serotypes B:2,5 and E:2,5. Vet Rec (2001) 1.38

Localization of the rap1GAP catalytic domain and sites of phosphorylation by mutational analysis. Mol Cell Biol (1992) 1.29

Structure of the poly(G) polymerase component of the bacteriophage f2 replicase. Proc Natl Acad Sci U S A (1971) 1.21

Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Dev Ind Pharm (1998) 1.11

Investigation of specific substitutions in virulence genes characterizing phenotypic groups of low-virulence field strains of Listeria monocytogenes. Appl Environ Microbiol (2005) 1.04

Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix. Int J Pharm (2001) 1.03

Precipitating factors of transient global amnesia. J Neurol (1999) 1.02

Experimental validation of low virulence in field strains of Listeria monocytogenes. Infect Immun (2003) 1.02

The behavioral effects of REM sleep deprivation in rats. Psychophysiology (1970) 1.01

Carboxymethylcellulose: effect of degree of polymerization and substitution on tablet disintegration and dissolution. J Pharm Sci (1981) 0.99

The nucleotide sequence of the repeating unit in the oocyte 5S ribosomal DNA of Xenopus laevis. Cold Spring Harb Symp Quant Biol (1978) 0.97

Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. Eur J Pharm Biopharm (2000) 0.90

Correction: nucleotide sequence of Ac. Cell (1984) 0.90

Deletion mutants of Xenopus laevis 5S ribosomal DNA. Cell (1979) 0.89

Protection against haemorrhagic septicaemia induced by vaccination of buffalo calves with an improved oil adjuvant vaccine. FEMS Microbiol Lett (1997) 0.89

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients. HIV Med (2004) 0.88

UK acquired hepatitis E--An emerging problem? J Med Virol (2006) 0.88

Factor requirement of the bacteriophage f2 replicase. Nat New Biol (1973) 0.87

Binding of host iron-binding proteins and expression of iron-regulated membrane proteins by different serotypes of Pasteurella multocida causing haemorrhagic septicaemia. Microb Pathog (1996) 0.87

Effect of formulation and process variables on porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug. J Control Release (2000) 0.86

Properties of the phage f2 replicase. II. Comparative studies on the ribonucleic acid-dependent and poly (C)-dependent activities of the replicase. J Biol Chem (1972) 0.85

Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III study. Ann Oncol (2012) 0.85

Phase I/II study of a 3 weekly oral taxane (DJ-927) in patients with recurrent, advanced non-small cell lung cancer. J Thorac Oncol (2008) 0.84

A tool-kit for cDNA microarray and promoter analysis. Bioinformatics (2003) 0.84

Screening for novel antimicrobials from encoded combinatorial libraries by using a two-dimensional agar format. Antimicrob Agents Chemother (1998) 0.83

Improving quantitative exposure assessment by considering genetic diversity of B. cereus in cooked, pasteurised and chilled foods. Int J Food Microbiol (2008) 0.82

Enteral, oral, and rectal absorption of ceftriaxone using glyceride enhancers. Chemotherapy (1988) 0.82

Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes. Pharm Dev Technol (2001) 0.82

Properties of the phage f2 replicase. I. Optimal conditions for replicase activity and analysis of the polynucleotide product synthesized in vitro. J Biol Chem (1972) 0.82

Acute behavioural effects of corticosterone lack specificity but show marked context-dependency. J Neuroendocrinol (1997) 0.82

Structure of deletion derivatives of a recombinant plasmid containing the transposable element Tn9 in the spacer sequence of Xenopus laevis 5S DNA. Cold Spring Harb Symp Quant Biol (1979) 0.80

Transposon tagging and the study of root development in Arabidopsis. Gravit Space Biol Bull (1998) 0.79

Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. J Microencapsul (2000) 0.78

Response to "Logistic regression in signal detection: another piece added to the puzzle". Clin Pharmacol Ther (2013) 0.77

Mechanical properties of single pellets containing acrylic polymers. Pharm Dev Technol (1996) 0.77

Comparison of various injectable protein-loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices: in-situ-formed implant versus in-situ-formed microspheres versus isolated microspheres. Pharm Dev Technol (2000) 0.77

The effects of the alpha 2 adrenoceptor blocker idazoxan on defeat-induced immobility and plasma corticosterone in rats is antagonized by administration of adrenocorticotrophin-antiserum. Behav Pharmacol (1997) 0.76

Negative effect of the 5'-untranslated leader sequence on Ac transposon promoter expression. Plant Mol Biol (1999) 0.76

Dynamic technique: three-flap SMAS. Plast Reconstr Surg (1999) 0.75

Design of a high-sensitivity negative ion source time-of-flight mass analyzer assembly created by cylindrical electrodes with a common axis. J Mass Spectrom (2004) 0.75

Effects of post-hypnotic suggestions on muscular endurance. Percept Mot Skills (1975) 0.75

Barbara McClintock - June 16, 1902-September 2, 1992. Biogr Mem Natl Acad Sci (1995) 0.75

The effect of visual deprivation on gastrointestinal ulceration. Physiol Behav (1978) 0.75

[Severe hypophosphatemia and coma in a critically ill patient]. Rev Esp Anestesiol Reanim (1995) 0.75

[Acute hemodynamic effects of nifedipine in hypertensive patients]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna (1985) 0.75

Percutaneous needle biopsy in exudative ascites. J Pak Med Assoc (1996) 0.75

Critical processing factors affecting rheological behavior of a wax based formulation. Eur J Pharm Biopharm (2002) 0.75

Evolution of the vertical scar in Lejour's mastoplasty technique. Aesthetic Plast Surg (1996) 0.75

Vacuolating cytotoxic activity of Pasteurella multocida causing haemorrhagic septicaemia in buffalo and cattle. FEMS Microbiol Lett (1996) 0.75

Aberrations of the cylindrical mirror time-of-flight mass spectrometers with oblique incidence. J Mass Spectrom (2005) 0.75

Evaluation of drug formulations using LD50 testing in mice. J Pharm Sci (1977) 0.75

Stability of a hydrophobic drug in presence of hydrous and anhydrous lactose. Eur J Pharm Biopharm (1998) 0.75

Modeling relaxation and jamming in granular media. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 0.75